Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-11-14 Option Award | 2021-11-16 9:12 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Andrews Timothy K. General Counsel | 54,132 | $0 | 54,132 (Direct) | View |
Ownership | 2021-03-11 9:38 pm | N/A 2030-12-17 | Prometheus Biosciences Inc. | RXDX | Andrews Timothy K. General Counsel | 0 | $0 | 153,495 (Direct) | View |
| 2019-08-06 Disposition | 2019-08-08 4:44 pm | N/A 2028-06-01 | Sienna Biopharmaceuticals Inc. | SNNA | Andrews Timothy K. General Counsel & Secretary | 131,808 | $0 | 302,366 (Direct) | View |
| 2019-08-06 Option Award | 2019-08-08 4:44 pm | N/A 2027-07-26 | Sienna Biopharmaceuticals Inc. | SNNA | Andrews Timothy K. General Counsel & Secretary | 181,808 | $0 | 302,366 (Direct) | View |
| 2019-07-02 Tax Withholding | 2019-07-03 1:42 pm | N/A N/A | Sienna Biopharmaceuticals Inc. | SNNA | Andrews Timothy K. General Counsel & Secretary | 4,095 | $0.76 | 120,558 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 6:13 pm | 2019-01-01 2029-01-01 | Sienna Biopharmaceuticals Inc. | SNNA | Andrews Timothy K. General Counsel & Secretary | 108,290 | $0 | 210,443 (Direct) | View |
| 2018-06-01 Option Award | 2018-06-04 9:23 pm | N/A 2028-06-01 | Sienna Biopharmaceuticals Inc. | SNNA | Andrews Timothy K. General Counsel & Secretary | 60,000 | $0 | 138,699 (Direct) | View |